|
Tuberculosis remains a major public health
problem in India. Every year approximately 18 lakh people develop TB and about 4 lakh die from
it. India accounts for one fifth of global
incidence of TB and tops the list of 22 high TB
burden countries. Unless sustained and
appropriate action is taken, approximately 20
lakh people in India are estimated to die of TB
in next five years. TB kills more adults in
India than any other infectious disease.
In India, EVERY DAY:
-
More than 40,000 people
become newly infected with the tubercle
bacilli.
-
More than 5000 develop TB
disease
-
More than 1000 people die of
TB (i.e. 1 death every 11/2
minutes)
Despite the existence
of a National Tuberculosis Programme since 1962,
there was little impact on the TB burden till
1992. This programme could not achieve the
objectives because of low priority, managerial
weaknesses, over dependence on X-rays for
diagnosis and inadequate funding. Incomplete
treatment was the norm rather than exception due
to low rates of treatment adherence and lack of
supervision.
Tuberculosis is a
barrier to socio-economic development and costs
the country more than Rs.12, 000 crore per year.
The greatest burden of tuberculosis incidence
and mortality in India is in adults aged 15 to
60 years, which include the most productive
members of society. TB kills more women than all
causes of maternal mortality.
Every year due to TB:
•
More than 17 crore work-days are
lost
•
Nearly 3 lakh school children
dropout from the schools
•
More than 1 lakh women are
rejected by their families
The goal of RNTCP is
to decrease mortality and morbidity due to TB
and cut transmission of infection until TB
ceases to be a major public health problem. The
goal is achieved through the objectives: - The
objective of RNTCP are to achieve and maintain
at least 85 % cure rate of new sputum
smear-positive patients and to achieve and
maintain detection of at least 70 % of such
cases in the population.
The Revised National
Tuberculosis Control Programme (RNTCP) uses the
DOTS (Directly Observed Treatment Short course
Chemotherapy) strategy, which is based on
Tuberculosis research done in India. “The DOTS
Strategy” is globally accepted standard for
diagnosis and treatment of Tuberculosis.
ADVANTAGE OF DOTS METHOD
̃ Directly
observed.
Short Course.
̃
Near the door steps.
̃
Full course of treatment in a single pack for a
single patient.
Sputum Follow-up examination at intervals.
̃
Good quality drugs.
̃
Free of cost.
̃
Not required to come frequently to Hospitals.
However, DOT is not supervised
swallowing but a service to the patient. It
helps to develop a human bond, between the
patients and the treatment observer, which
increases the probability of
the patient completing treatment with short
course chemotherapy it is earlier to prevent
drug resistance by using directly observed
treatment and achieve high cure rate.
ORAGANIZATIONAL ASPECTS OF RNTCP
DISTRICT TUBERCULOSIS CENTER
District Tuberculosis Officer (Nodal Officer)

                       
Dhenkanal TU
K.Nagar TU Hindol TU
M.O TU
M.O TU M.O
TU
S.T.S
S.T.S
S.T.S
S.T.L.S
S.T.L.S
S.T.L.S
( D.M.C)
(D.M.C)
(D.M.C)
   Designated
Microscopic Centre
Designated Microscopic Centre
Designated Microscopic Centre
Dhenkanal
K.Nagar
Hindol
Beltikiri
Analaberini
Rasol
Sriramchandrapur Mathakaragola Khajuriakata
Bhuban Odapada
Birasal
Parjang
BASIC INFORMATION
Total Population (2009
estimated Mid year)
11, 64,411
S C
population
2, 12, 997
S T
population 1,
57,996
Programme Started
on: 10.11.2003
No. of trained DOTS
Providers
1566
PHYSICAL ACHIEVEMENTS:
|
|
Jan toDec-04 |
Jan to Dec-05 |
Jan to Dec-06 |
Jan to Dec07 |
Jan to Dec-08 |
|
Total no of
Sputum Examined |
4599 |
4867 |
4594 |
6036 |
1722 |
|
Total no of
Sputum +ve patients |
633 |
587 |
545 |
733 |
697 |
|
Total Patients
Treated Positive+ Negative) |
1323 |
1152 |
1080 |
1272 |
1209 |
|
Total no of
Extra Pulmonarypatients put on Dots |
143 |
218 |
155 |
207 |
218 |
|
Total no of
Re-Treatment Cases |
130 |
141 |
180 |
166 |
44 |
|
Total no of
Patients Cured |
50 |
406 |
394 |
401 |
513 |
|
Total no of
Patients Completed |
84 |
630 |
517 |
445 |
493 |
|
Cured Rate |
79% |
81.2% |
84.4% |
88.52% |
88.64% |
|
Sputum
Conversion |
|
84.92% |
94.26% |
91.02% |
91.22% 92.86% |
|
Success Rate |
84% |
92.5% |
88.95% |
91.16% |
90.68% |
|
Death Rate |
6.02%
|
6.02%
|
5.23% |
6.18% |
4% |
|
Defaulter Rate |
4.42% |
4.42% |
4.6% |
2.20% |
3.25% |
FLOW CHART OF TREATMENT


|